Improving Patient Reported Outcomes and Preventing Depression and Anxiety in Older Adults With Knee Osteoarthritis: Results of a Sequenced Multiple Assignment Randomized Trial (SMART) Study.


Journal

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry
ISSN: 1545-7214
Titre abrégé: Am J Geriatr Psychiatry
Pays: England
ID NLM: 9309609

Informations de publication

Date de publication:
10 2019
Historique:
received: 23 08 2018
revised: 27 02 2019
accepted: 18 03 2019
pubmed: 3 5 2019
medline: 4 9 2020
entrez: 4 5 2019
Statut: ppublish

Résumé

Older adults with knee osteoarthritis (OA) and comorbid subsyndromal depressive symptoms are at elevated risk for incidental major depression or anxiety disorders. Using an indicated prevention paradigm, the authors conducted a sequenced multiple assignment randomized trial (SMART) to: 1) evaluate the effect of cognitive behavioral therapy (CBT) and physical therapy (PT), together with the temporal ordering of these interventions, on patient-reported global impression of change (P-GIC), mood, anxiety, and pain; and 2) compare the strategies' impact on incidence of common psychiatric disorders over 12-months. This intervention development trial compared four adaptive strategies delivered in two stages (each up to 8 weeks), contrasted with enhanced usual care (EUC). The strategies were CBT followed by an increased dose of CBT (CBT-CBT), CBT followed by PT (CBT-PT), PT followed by an increased dose of PT (PT-PT), and PT followed by CBT (PT-CBT). Participants (n = 99) were aged 60 years and older and met clinical criteria for knee OA and subthreshold depression. Response was defined as at least "much better" on the P-GIC. Participants were assessed quarterly for 12 months for incidence of psychiatric disorders. Stage 1 response was higher for PT (47.5%) compared to CBT (20.5%). Non-responders receiving an additional dose of the same intervention experienced a response rate of 73%, higher than for switching to a different intervention. All strategies were superior to EUC (5%). Although not powered to detect effects on disorders, neither intervention strategy nor response status affected 12-month incidence of depression and anxiety disorders. As response rates were similar for PT-PT and CBT-CBT, it may be dose and not type of these interventions that are necessary for clinical benefit. For non-responders, this finding may guide providers to stay the clinical course for up to 12 weeks before switching. These results support future trials of SMART designs in late-life depression prevention.

Identifiants

pubmed: 31047790
pii: S1064-7481(19)30303-3
doi: 10.1016/j.jagp.2019.03.011
pmc: PMC6739151
mid: NIHMS1528175
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT01530204']

Types de publication

Clinical Trial, Phase IV Journal Article Randomized Controlled Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1035-1045

Subventions

Organisme : NIMH NIH HHS
ID : P30 MH090333
Pays : United States

Informations de copyright

Copyright © 2019 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights reserved.

Références

Ann Intern Med. 2000 Feb 1;132(3):173-81
pubmed: 10651597
Br J Psychiatry. 2000 Apr;176:373-8
pubmed: 10827887
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Pain. 2002 Nov;100(1-2):55-64
pubmed: 12435459
Arch Intern Med. 2003 Nov 10;163(20):2433-45
pubmed: 14609780
J Affect Disord. 2004 Apr;79(1-3):71-9
pubmed: 15023482
J Neurosci. 2004 Nov 17;24(46):10410-5
pubmed: 15548656
Stat Med. 2005 May 30;24(10):1455-81
pubmed: 15586395
Phys Ther. 2005 Sep;85(9):907-71
pubmed: 16117601
Phys Ther. 2005 Dec;85(12):1301-17
pubmed: 16305269
Arch Gen Psychiatry. 2006 Mar;63(3):290-6
pubmed: 16520434
Psychosom Med. 2006 Mar-Apr;68(2):262-8
pubmed: 16554392
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Man Ther. 2007 May;12(2):109-18
pubmed: 16777467
J Rheumatol. 2007 Jan;34(1):172-80
pubmed: 17216685
J Natl Cancer Inst. 2007 Nov 7;99(21):1577-82
pubmed: 17971533
Ann Rheum Dis. 2008 Oct;67(10):1390-8
pubmed: 18245111
Psychol Med. 2008 Nov;38(11):1639-50
pubmed: 18298879
JAMA. 2008 May 28;299(20):2391-400
pubmed: 18505948
Arch Gen Psychiatry. 2009 Mar;66(3):297-304
pubmed: 19255379
J Am Geriatr Soc. 2009 Aug;57(8):1331-46
pubmed: 19573219
Arch Phys Med Rehabil. 2009 Nov;90(11):1866-73
pubmed: 19887210
J Psychiatr Res. 2011 May;45(5):626-9
pubmed: 21035130
Clin Ther. 2011 Dec;33(12):1914-31
pubmed: 22088416
Biostatistics. 2013 Apr;14(2):299-312
pubmed: 23178734
Lancet. 2012 Dec 15;380(9859):2163-96
pubmed: 23245607
Lancet. 2012 Dec 15;380(9859):2197-223
pubmed: 23245608
Brain. 2013 Mar;136(Pt 3):815-27
pubmed: 23436504
Osteoarthritis Cartilage. 2014 Mar;22(3):363-88
pubmed: 24462672
Psychiatr Serv. 2014 Jun 1;65(6):765-73
pubmed: 24632760
Semin Arthritis Rheum. 2014 Dec;44(3):253-63
pubmed: 24953861
Ophthalmology. 2014 Nov;121(11):2204-11
pubmed: 25016366
Clin Geriatr Med. 2014 Aug;30(3):517-34
pubmed: 25037293
Transl Behav Med. 2014 Sep;4(3):260-74
pubmed: 25264466
J Anxiety Disord. 2014 Dec;28(8):845-50
pubmed: 25445074
Psychother Psychosom. 2015;84(6):348-58
pubmed: 26398885
Am J Geriatr Psychiatry. 2016 Jan;24(1):94-102
pubmed: 26706911
Am J Geriatr Psychiatry. 2016 Jun;24(6):433-43
pubmed: 26809601
JAMA Psychiatry. 2018 Jan 1;75(1):56-64
pubmed: 29117275
J Rheumatol. 1988 Dec;15(12):1833-40
pubmed: 3068365
J Clin Psychiatry. 1987 Aug;48(8):314-8
pubmed: 3611032
Arthritis Rheum. 1986 Aug;29(8):1039-49
pubmed: 3741515
Annu Rev Med. 1972;23:407-12
pubmed: 4566487
Am J Community Psychol. 1995 Apr;23(2):199-222
pubmed: 7572830
Am J Public Health. 1994 Mar;84(3):351-8
pubmed: 8129049
Clin Geriatr Med. 1998 Aug;14(3):435-54
pubmed: 9664101
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538

Auteurs

Jordan F Karp (JF)

Department of Psychiatry (JFK, MAD, DKW, AG, MB, CFR). Electronic address: karpjf@upmc.edu.

Jun Zhang (J)

Department of Biostatistics, Graduate School of Public Health (JZ, ASW, SA, MAD).

Abdus S Wahed (AS)

Department of Biostatistics, Graduate School of Public Health (JZ, ASW, SA, MAD).

Stewart Anderson (S)

Department of Biostatistics, Graduate School of Public Health (JZ, ASW, SA, MAD).

Mary Amanda Dew (MA)

Department of Psychiatry (JFK, MAD, DKW, AG, MB, CFR); Department of Biostatistics, Graduate School of Public Health (JZ, ASW, SA, MAD); Department of Epidemiology.

G Kelley Fitzgerald (GK)

School of Health and Rehabilitation Sciences (GKF), University of Pittsburgh, Pittsburgh.

Debra K Weiner (DK)

Department of Psychiatry (JFK, MAD, DKW, AG, MB, CFR); Department of Psychiatry and Department of Medicine (DKW), University of Pittsburgh and University of Pittsburgh School of Medicine, Pittsburgh.

Steve Albert (S)

Behavioral and Community Health Sciences.

Ari Gildengers (A)

Department of Psychiatry (JFK, MAD, DKW, AG, MB, CFR).

Meryl Butters (M)

Department of Psychiatry (JFK, MAD, DKW, AG, MB, CFR).

Charles F Reynolds (CF)

Department of Psychiatry (JFK, MAD, DKW, AG, MB, CFR).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH